Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study

Clinical Nephrology

Volumn 89, Issue 5, 2018, Pages 363-370

  Goyal, Kamal Kumar ^a   Saha, Abhijeet ^c   Sahi, Puneet Kaur ^c   Kaur, Manpreet ^a   Dubey, Nand Kishore ^a   Goyal, Parul ^b   Upadhayay, Ashish Dutt ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

^c KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

Author keywords

Children; CKD; Hepcidin; IL 6; TNF

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; TRANSFERRIN; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER;

ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; ANEMIA; ARTICLE; CASE CONTROL STUDY; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC UREMIC SYNDROME; HORSESHOE KIDNEY; HUMAN; IRON DEFICIENCY; KIDNEY DYSPLASIA; KIDNEY HYPOPLASIA; KIDNEY INFARCTION; MALE; MEDULLARY SPONGE KIDNEY; OBSTRUCTIVE UROPATHY; REFLUX NEPHROPATHY; BLOOD; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HEPCIDINS; HUMANS; INTERLEUKIN-6; RENAL INSUFFICIENCY, CHRONIC;

EID: 85045646464     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN109132     Document Type: Article

References (29)

1. Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol. 2010; 25: 1699-1706
2. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010; 116: 4754-4761
3. Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010; 55: 726-741
4. Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? Clin J Am Soc Nephrol. 2006; 1 (Suppl 1): S9-S18
5. Davidkova S, Prestidge TD, Reed PW, Kara T, Wong W, Prestidge C. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis. Pediatr Nephrol. 2016; 31: 819-826
6. Bamgbola OF, Kaskel FJ, Coco M. Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol. 2009; 24: 571-579
7. Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res. 2007; 30: 15-30
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (Suppl 1): S1-S266
9. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20: 629-637
10. Kidney Disease; Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2009; 2: 279-335
11. Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One. 2014; 9: e99781
12. KDOQI; National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006; 47 (Suppl 3): S11-S145
13. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1051-1056
14. Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol. 2015; 30: 635-643
15. Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates. J Clin Lab Anal. 2013; 27: 504-510
16. Goyal H, Mohanty S, Sharma M, Rani A. Study of anemia in nondialysis dependent chronic kidney disease with special reference to serum hepcidin. Indian J Nephrol. 2017; 27: 44-50
17. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002; 29: 327-
18. Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009; 4: 1384-1387.
19. Means RT. Hepcidin and cytokines in anaemia. Hematology. 2004; 9: 357-362
20. Means RT. Hepcidin and cytokines in anaemia. Hematology. 2004; 9: 357-362
21. Ganz T. Molecular control of iron transport. J Am Soc Nephrol. 2007; 18: 394-400
22. Swinkels DW, Wetzels JF. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2008; 23: 2450-2453
23. Akchurin O, Sureshbabu A, Doty SB, Zhu YS, Patino E, Cunningham-Rundles S, Choi ME, Boskey A, Rivella S. Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease. Am J Physiol Renal Physiol. 2016; 311: F877-F889
24. Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010; 116: 3627-3634
25. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113: 1271-1276
26. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, Umehara Y, Wano Y, Said JW, Koeffler HP. Expression of hepcidin is downregulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood. 2005; 105: 376-381
27. Zwolinska D, Medynska A, Szprynger K, Szczepanska M. Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis. Nephron. 2000; 86: 441-446
28. Gaillard CA, Bock AH, Carrera F, Eckardt K-U, Van Wyck DB, Bansal SS, Cronin M, Meier Y, Larroque S, Roger SD, Macdougall IC. Hepcidin response to iron therapy in patients with non-dialysis dependent CKD: An analysis of the FIND-CKD trial. PLoS One. 2016; 11: e0157063
29. Przybyszewska J, Zekanowska E. The role of hepcidin and haemojuvelin in the pathogenesis of iron disorders in patients with severe malnutrition. Ann Agric Environ Med. 2014; 21: 336-338